Computational tool developed to predict immunotherapy outcomes for patients with metastatic breast c…

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy. The work by computational…

Click here to view the original article.